4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-24-007733
Options or other derivatives
- Director acquired 17,884 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Nolet Chris Director | 2024-01-25 | Grant or award · Stock Option (right to buy) | +17,884 | 17,884 | D | ||
Loading xslF345X05/tm244377-2_4seq1.xml…